Rheumatic conditions are associated with dermatological manifestations some of which are commonly known and others not so well known. In this slideshow, we highlight four conditions that should be on your radar.
Rheumatology Network Editorial Staff
The clinical burden of fracture on Medicare fee-for-service beneficiaries is significant, with patients continuing to experience additional fractures at high rates. The survival after a subsequent fracture is approximately 180 days, shows a report issued in August by the National Osteoporosis Foundation
In this slideshow, we highlight 12 recommendations for assessing MRI lesions on the sacroiliac joints of patients with spondyloarthritis. The recommendations were made by the Assessment of Spondyloarthritis International Society (ASAS) MRI working group and published in the British journal Annals of the Rheumatic Diseases earlier this year.
In this installment of our psoriatic arthritis quiz, we focus on features associated with the five types of psoriatic arthritis. Can you identify all types of psoriatic arthritis and address how best to treat each condition?
A new survey by the American College of Rheumatology shows that one in four Americans have rheumatic disease. Among the surveyed patients, 50 percent were forced into step therapy.
Patient visits can be highly complex and stressful for both patient and physician, but good manners can make the difference between a successful visit and a poor one. In this slideshow, we highlight 13 tips that may lead to better patient encounters.
In today's installment of our psoriatic arthritis quiz, we revisit some recently published studies and news headlines. What new treatment for psoriatic arthritis has gone before the FDA for approval? Test your knowledge on this and other recent headlines in this quiz.
The bisphosphonate alendronate (Binosto and Fosamax) can effectively maintain the gains in bone mineral density achieved with a year-long course of denosumab treatment in 91 percent of 126 patients who participated in a randomized clinical trial presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
Patients with atrial fibrillation are commonly prescribed oral anticoagulants for stroke prevention, but in older patients at risk for osteoporosis, treatment with blood thinners may heighten osteoporosis risk, according to a study presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
The cost of treating osteoporosis in the United states has risen 118 percent over the last 19 years, shows an analysis presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.